Monogram Orthopaedics (MGRM) Projected to Post Quarterly Earnings on Monday

Monogram Orthopaedics (NASDAQ:MGRM) is expected to post its Q1 2025 quarterly earnings results before the market opens on Monday, May 12th. Analysts expect the company to announce earnings of ($0.10) per share for the quarter.

Monogram Orthopaedics (NASDAQ:MGRM) last issued its quarterly earnings data on Wednesday, March 12th. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.03. On average, analysts expect Monogram Orthopaedics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Monogram Orthopaedics Stock Up 0.7 %

NASDAQ MGRM opened at $2.69 on Friday. The firm has a market capitalization of $94.93 million, a price-to-earnings ratio of -5.72 and a beta of 0.74. Monogram Orthopaedics has a 52 week low of $1.84 and a 52 week high of $4.21. The company has a fifty day moving average of $2.73 and a two-hundred day moving average of $2.54.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the stock. Roth Mkm increased their target price on shares of Monogram Orthopaedics from $4.00 to $5.40 and gave the stock a “buy” rating in a report on Tuesday, March 18th. Roth Capital set a $5.40 price objective on shares of Monogram Orthopaedics in a research report on Tuesday, March 18th.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.